Hytrin 2 Tablet contains Terazosin 2 mg, an alpha-1 adrenergic receptor antagonist used primarily in the management of hypertension and benign prostatic hyperplasia (BPH). Terazosin works by selectively blocking alpha-1 receptors in vascular smooth muscle and the prostate, leading to vasodilation and relaxation of the bladder neck and prostate muscles. This dual action results in lowered blood pressure and improved urinary flow in patients with BPH. Hytrin 2 Tablet is indicated for the treatment of essential hypertension, either as monotherapy or in combination with other antihypertensive agents, and for the symptomatic relief of urinary obstruction associated with BPH. The medication is administered orally, with dosing individualized based on patient response and tolerance, typically starting at a low dose to minimize the risk of orthostatic hypotension. Common side effects may include dizziness, headache, fatigue, and nasal congestion, which often diminish with continued use. Patients should be advised to rise slowly from sitting or lying positions to reduce the risk of dizziness and falls. Hytrin 2 Tablet should be used cautiously in patients with a history of cardiovascular disease or hepatic impairment. Regular monitoring of blood pressure and clinical status is recommended to ensure therapeutic efficacy and safety.

Dosage & How to Use